National Institute of Biology creates gene therapy spin-off

Ljubljana, 21 April - The National Institute of Biology (NIB) has licenced its gene therapy know-how and technology to a spin-off called Niba Labs, which will develop and commercialise technologies for the characterisation and quantification of therapeutic viruses used in gene therapy.

Ljubljana The National Institute of Biology creates a gene therapy spin-off called Niba Labs. Photo: Nebojša Tejić/STA

Ljubljana
The National Institute of Biology creates a gene therapy spin-off called Niba Labs.
Photo: Nebojša Tejić/STA

The rest of this news item is available to subscribers.
The news item consists of 657 characters (without spaces) or 126 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

sm/nd/zm
© STA, 2021

The STA web pages use cookies to ensure proper functioning of all page features. By using our website, you agree to the use of cookies on all STA web pages.

I want to know more